217 related articles for article (PubMed ID: 29202196)
1. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
[TBL] [Abstract][Full Text] [Related]
2. DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis.
Ritchey L; Ha T; Otsuka A; Kabashima K; Wang D; Wang Y; Lowy DR; Tosato G
Oncogene; 2019 Nov; 38(45):7046-7059. PubMed ID: 31409902
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
[TBL] [Abstract][Full Text] [Related]
4. A tumor suppressor DLC1: The functions and signal pathways.
Zhang Y; Li G
J Cell Physiol; 2020 Jun; 235(6):4999-5007. PubMed ID: 31773748
[TBL] [Abstract][Full Text] [Related]
5. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.
Shih YP; Yuan SY; Lo SH
Cancer Lett; 2017 Jul; 398():46-51. PubMed ID: 28408355
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
Dai Z; Jin Y
Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
[TBL] [Abstract][Full Text] [Related]
8. H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells.
Ma L; Zhu WZ; Liu TT; Fu HL; Liu ZJ; Yang BW; Song TY; Li GR
Asian Pac J Cancer Prev; 2015; 16(4):1637-42. PubMed ID: 25743845
[TBL] [Abstract][Full Text] [Related]
9. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.
Shih YP; Takada Y; Lo SH
Mol Cancer Res; 2012 Jan; 10(1):34-9. PubMed ID: 22064653
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
Ullmannova V; Popescu NC
Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
[TBL] [Abstract][Full Text] [Related]
12. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
13. miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-κB feedback loops.
Wang T; Xu X; Xu Q; Ren J; Shen S; Fan C; Hou Y
Oncogene; 2017 Jun; 36(23):3240-3251. PubMed ID: 27991929
[TBL] [Abstract][Full Text] [Related]
14. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
[TBL] [Abstract][Full Text] [Related]
16. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
Enesa K; Moll HP; Luong L; Ferran C; Evans PC
FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
[TBL] [Abstract][Full Text] [Related]
17. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
[TBL] [Abstract][Full Text] [Related]
18. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis.
Wang Y; Lei R; Zhuang X; Zhang N; Pan H; Li G; Hu J; Pan X; Tao Q; Fu D; Xiao J; Chin YE; Kang Y; Yang Q; Hu G
J Clin Invest; 2014 Apr; 124(4):1646-59. PubMed ID: 24590291
[TBL] [Abstract][Full Text] [Related]
19. DLC1 as a regulator of proliferation, invasion, cell cycle, and apoptosis in cutaneous squamous cell carcinoma.
Yang C; Wu D; Jia J; Liu D; Li Z; Zhang C; Li M; Xia Y
Tumour Biol; 2013 Oct; 34(5):2633-43. PubMed ID: 23625658
[TBL] [Abstract][Full Text] [Related]
20. Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration
Gao J; Ma F; Wang X; Li G
Food Funct; 2020 Nov; 11(11):9573-9584. PubMed ID: 33150340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
